BR112014027841A8 - Derivado de pirazola e o uso do mesmo para fins médicos - Google Patents

Derivado de pirazola e o uso do mesmo para fins médicos

Info

Publication number
BR112014027841A8
BR112014027841A8 BR112014027841A BR112014027841A BR112014027841A8 BR 112014027841 A8 BR112014027841 A8 BR 112014027841A8 BR 112014027841 A BR112014027841 A BR 112014027841A BR 112014027841 A BR112014027841 A BR 112014027841A BR 112014027841 A8 BR112014027841 A8 BR 112014027841A8
Authority
BR
Brazil
Prior art keywords
medical purposes
present
pyrazole derivative
constipation
prevention
Prior art date
Application number
BR112014027841A
Other languages
English (en)
Other versions
BR112014027841B1 (pt
BR112014027841A2 (pt
Inventor
Hidetoshi Isawa
Itaru Miyashita
Masaaki Takemura
Masayuki Isaji
Yukihiko Hotei
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of BR112014027841A2 publication Critical patent/BR112014027841A2/pt
Publication of BR112014027841A8 publication Critical patent/BR112014027841A8/pt
Publication of BR112014027841B1 publication Critical patent/BR112014027841B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02Heterocyclic radicals containing only nitrogen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

derivado de pirazola e o uso do mesmo para fins médicos. a presente invenção proporciona derivados de pirazola, o uso dos mesmos para fins médicos e assim por diante. mais particularmente, a presente invenção se refere a produtos farmacêuticos úteis para a prevenção ou o tratamento de constipação, que compreende como um ingrediente ativo 3-(3-{4-[3-(beta-d-glicopiranosiloxi)-5-isopropil-1h-pirazol-4-ilmetil]-3-metilfenoxi}propilamino)-2,2-dimetilpropionamida, ou um sal farmaceuticamente aceitável do mesmo. os produtos farmacêuticos da pre-sente invenção exercem um efeito de aumentar a frequência do movimento dos intestinos ou semelhante, e são úteis para a prevenção ou o tratamento de constipação.
BR112014027841-5A 2012-05-07 2013-05-02 Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação BR112014027841B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012-105847 2012-05-07
JP2012105847 2012-05-07
PCT/JP2013/062755 WO2013168671A1 (ja) 2012-05-07 2013-05-02 ピラゾール誘導体及びその医薬用途

Publications (3)

Publication Number Publication Date
BR112014027841A2 BR112014027841A2 (pt) 2017-06-27
BR112014027841A8 true BR112014027841A8 (pt) 2021-09-28
BR112014027841B1 BR112014027841B1 (pt) 2022-08-09

Family

ID=49550709

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014027841-5A BR112014027841B1 (pt) 2012-05-07 2013-05-02 Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação

Country Status (16)

Country Link
US (2) US9273085B2 (pt)
EP (1) EP2848254B1 (pt)
JP (2) JP5663699B2 (pt)
KR (1) KR101868991B1 (pt)
CN (1) CN104284665B (pt)
AU (1) AU2013258566B2 (pt)
BR (1) BR112014027841B1 (pt)
CA (1) CA2872002C (pt)
DK (1) DK2848254T3 (pt)
ES (1) ES2601127T3 (pt)
HK (1) HK1204773A1 (pt)
MX (1) MX359988B (pt)
PL (1) PL2848254T3 (pt)
PT (1) PT2848254T (pt)
RU (1) RU2602739C2 (pt)
WO (1) WO2013168671A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3023102T (lt) 2010-11-08 2018-09-25 Albireo Ab Ibat inhibitoriai, skirti kepenų ligų gydymui
BR112014027841B1 (pt) * 2012-05-07 2022-08-09 Kissei Pharmaceutical Co., Ltd Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação
KR102078433B1 (ko) 2013-02-04 2020-02-17 다이쇼 세이야꾸 가부시끼가이샤 변비증의 예방 또는 치료약
US10709755B2 (en) 2014-06-25 2020-07-14 Elobix Ab Solid formulation and method for preventing or reducing coloration thereof
KR102296314B1 (ko) * 2014-06-25 2021-09-01 이에이 파마 가부시키가이샤 고형 제제 및 그의 안정화 방법
US11596644B2 (en) 2018-03-28 2023-03-07 Avolynt Method for treating post-prandial hypoglycemia
CN112449637B (zh) 2018-06-05 2024-03-19 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
SG11202012170PA (en) 2018-06-20 2021-01-28 Albireo Ab Pharmaceutical formulation of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
KR20220109450A (ko) 2019-12-04 2022-08-04 알비레오 에이비 벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의 이의 용도
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
EP4069247A1 (en) 2019-12-04 2022-10-12 Albireo AB Benzothiadiazepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
JP2023537285A (ja) 2020-08-03 2023-08-31 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2023549226A (ja) 2020-11-12 2023-11-22 アルビレオ エービー 進行性家族性肝内胆汁うっ滞症(pfic)を処置するためのオデビキシバット
EP4255565A1 (en) 2020-12-04 2023-10-11 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
WO2007127183A1 (en) * 2006-04-26 2007-11-08 Genentech, Inc. Phosphoinositide 3-kinase inhibitor compounds and pharmaceutical compositions containing them
CA2709530C (en) 2007-12-27 2016-02-23 Kissei Pharmaceutical Co., Ltd. Monosebacate of pyrazole derivative
JP5467040B2 (ja) 2008-04-16 2014-04-09 キッセイ薬品工業株式会社 ピラゾール誘導体の1/2フマル酸塩
AR087701A1 (es) 2011-08-31 2014-04-09 Japan Tobacco Inc Derivados de pirazol con actividad inhibidora de sglt1
BR112014027841B1 (pt) * 2012-05-07 2022-08-09 Kissei Pharmaceutical Co., Ltd Uso de derivados de pirazola na fabricação de um fármaco para prevenir ou tratar constipação

Also Published As

Publication number Publication date
BR112014027841B1 (pt) 2022-08-09
WO2013168671A1 (ja) 2013-11-14
US9694027B2 (en) 2017-07-04
BR112014027841A2 (pt) 2017-06-27
JP6105546B2 (ja) 2017-03-29
JP2015083580A (ja) 2015-04-30
JP5663699B2 (ja) 2015-02-04
DK2848254T3 (en) 2016-10-31
HK1204773A1 (en) 2015-12-04
CA2872002C (en) 2019-01-15
AU2013258566B2 (en) 2017-03-16
US20160129031A1 (en) 2016-05-12
EP2848254B1 (en) 2016-08-03
PL2848254T3 (pl) 2017-03-31
US20150141631A1 (en) 2015-05-21
CA2872002A1 (en) 2013-11-14
EP2848254A4 (en) 2015-07-15
CN104284665A (zh) 2015-01-14
JPWO2013168671A1 (ja) 2016-01-07
KR20150013671A (ko) 2015-02-05
EP2848254A1 (en) 2015-03-18
US9273085B2 (en) 2016-03-01
RU2602739C2 (ru) 2016-11-20
MX359988B (es) 2018-10-18
PT2848254T (pt) 2016-10-05
MX2014013696A (es) 2015-02-05
KR101868991B1 (ko) 2018-06-19
RU2014149181A (ru) 2016-06-27
CN104284665B (zh) 2016-11-16
ES2601127T3 (es) 2017-02-14
AU2013258566A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
BR112014027841A8 (pt) Derivado de pirazola e o uso do mesmo para fins médicos
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
EA201490228A1 (ru) Новые производные трифторметилоксадиазола и их применение для лечения заболевания
BR112014031068A2 (pt) derivados piridinona e piridazinona
CL2015001667A1 (es) Derivados de manosa para tratar infecciones bacterianas.
BR112016005270A2 (pt) compostos de aza-piridona, composições farmacêuticas e seus usos
BR112015030315A2 (pt) derivado de 4-alquinilimidazol e medicamento compreendendo o mesmo como ingrediente ativo
BR112015019590A2 (pt) derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
BR112015030399B8 (pt) Derivados heterocíclicos, uso dos referidos derivados e composição farmacêutica para a prevenção ou tratamento de doenças associadas com a ativação da proteína stat3
DOP2014000059A (es) Derivados de estra–1,3,5(10),16–tetraen–3–carboxamida, procedimientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparación de medicamentos
CU20110088A7 (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibidores de quinasas dependientes de ciclina (cdk), producción y uso de los mismos como productos medicinales
BR112016026552A8 (pt) derivados de carboxamida, seus usos, composição farmacêutica, e combinação
CY1119542T1 (el) Προϊον μικρονισμου που περιλαμβανει οξεικη ουλιπρισταλη
BR112017004948A2 (pt) formulação farmacêutica.
BR112015004091A2 (pt) formulação de cápsula de compósito farmacêutico que compreende irbesartan e inibidor de hmg-coa redutase
NZ701103A (en) Solid state forms of n-((s)-2,3-dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide
BR112017009850A2 (pt) composto, composição, e, uso de uma quantidade melhoradora de hiv de um composto
BR112015015250A2 (pt) derivados de pirrolidina, composições farmacêuticas e usos dos mesmos
BR112017013031A2 (pt) derivados de imidazopiridazina ligados à heterociclila como inibidores de pi3kbeta
BR112012024346A2 (pt) agente terapêutico ou agente profilático para a doença de alzheimer
WO2016016820A3 (en) Anionically modified n-sulfonic polyallylamine derivative, pharmaceutical composition comprising the n-sulfonic polyallylamine derivative as the active substance and use of said derivate for the production of a medicine
EA201200799A1 (ru) Гепатопротекторное средство
BR112016030599A8 (pt) novos derivados de aminoalquilbenzotiazepina e suas utilizações
CU20150065A7 (es) Compuestos derivados de bencil 4-((2-(triazol-5-il)acetamido)metil)piperidin-1- carboxilato activos como inhibidores de autotaxina

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2462 DE 13/03/2018 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/05/2013, OBSERVADAS AS CONDICOES LEGAIS